Significant Publications on Infectious Diseases Pharmacotherapy in 2019.

Autor: Hendrickson JA; Department of Pharmacy Practice and Translational Research, 15507University of Houston College of Pharmacy, Houston, TX, USA., Spitznogle SL; Division of Pharmacy, 4002The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gonzales-Luna AJ; Department of Pharmacy Practice and Translational Research, 15507University of Houston College of Pharmacy, Houston, TX, USA., Babic JT; Department of Pharmacy, 23464Memorial Hermann-Texas Medical Center, Houston, TX, USA., Britt RS; Department of Pharmacy, 12338The University of Texas Medical Branch, Galveston, TX, USA., Knight JM; Department of Pharmacy, 23534Houston Methodist Hospital, Houston, TX, USA., Pham SN; Department of Pharmacy, 20116Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA., McDaneld PM; Division of Pharmacy, 4002The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jazyk: angličtina
Zdroj: Journal of pharmacy practice [J Pharm Pract] 2021 Oct; Vol. 34 (5), pp. 800-813. Date of Electronic Publication: 2020 Sep 16.
DOI: 10.1177/0897190020951348
Abstrakt: Purpose: To provide a summary of the most prominent peer-reviewed infectious diseases (ID) pharmacotherapy and Human Immunodeficiency Virus (HIV)-related articles published in 2019.
Summary: Houston Infectious Diseases Network (HIDN) members were asked to nominate articles that they believed were most influential within the ID and HIV pharmacotherapy science communities. A total of 48 general ID and 6 HIV-related articles were nominated. Following nominations, an online survey was distributed via e-mail to Society of Infectious Diseases Pharmacists (SIDP) members, with a total of 156 and 54 members voting for general ID and HIV-related articles, respectively. The results of this survey were ranked to determine the top 10 general ID and top HIV articles. The top articles were then summarized by HIDN members, including residents, fellows, and clinical pharmacists.
Conclusion: This review covers many of the most influential ID articles published in 2019, including 3 practice guideline updates. Due to the high rate of ID literature published each year, this review continues to help summarize these articles for the ID community, allowing clinicians to remain up-to-date on practice-changing publications in ID and HIV pharmacotherapy.
Databáze: MEDLINE